The short version of preclinical models fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-07-17 and is reviewed periodically as new material appears.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ | Nuclear receptor; not androgen receptor |
| Studied indications | Dyslipidemia; obesity; diabetes | Early clinical research; development discontinued |
| Rodent toxicity | Tumor formation in multiple tissues | Dose-dependent findings in some studies |
| Human approval | None | No approved therapeutic use |
| Typical analytical method | LC-MS/MS | Used for identity and quantification |
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
A mendelian randomization trial in humans found that a 1-standard deviation increase in genetically proxied LDL-C levels was associated with 1.2 years lower lifespan. This presents with an interesting candidate for increasing life span in select populations with such potentially deleterious mutations, since atherosclerosis is one of the leading causes of mortality through causing potentially fatal atherosclerotic cardiovascular disease. Considering many LDL-C lowering drugs are already approved to reduce mortality in select populations, there is certainly not a paucity of research.
The first timepieces to be worn, made in 16th-century Europe, were transitional in size between clocks and watches. These 'clock-watches' were fastened to clothing or worn on a chain around the neck. They were heavy drum shaped brass cylinders several inches in diameter, engraved and ornamented. They had only an hour hand. The face was not covered with glass, but usually had a hinged brass cover, often decoratively pierced with grillwork so the time could be read without opening. The movement was made of iron or steel and held together with tapered pins and wedges, until screws began to be used after 1550. Many of the movements included striking or alarm mechanisms. The shape later evolved into a rounded form; these were later called Nuremberg eggs. Still later in the century there was a trend for unusually shaped watches, and clock-watches shaped like books, animals, fruit, stars, flowers, insects, crosses, and skulls (Death's head watches) were made. Styles changed in the 17th century and men began to wear watches in pockets instead of as pendants (the woman's watch remained a pendant into the 20th century). This is said to have occurred in 1675 when Charles II of England introduced waistcoats. To fit in pockets, their shape evolved into the typical pocket watch shape, rounded and flattened with no sharp edges. Glass was used to cover the face beginning around 1610. Watch fobs began to be used, the name originating from the German word fuppe, a small pocket. The watch was wound and also set by opening the back and fitting a key to a square arbor, and turning it.
Ronald E. Blaylock, Managing Partner of GenNx360 Capital Partners Albert Bourla, CEO of Pfizer Mortimer J. Buckley, former CEO of The Vanguard Group Sue Desmond-Hellmann, former CEO of The Bill and Melinda Gates Foundation Joseph J. Echevarria, former CEO of Deloitte LLP Scott Gottlieb, former Commissioner of the FDA Helen Hobbs, Professor at the University of Texas Southwestern Medical Center Susan Hockfield, 16th President of the Massachusetts Institute of Technology Dan Littman, professor of Molecular Immunology at New York University Shantanu Narayen, CEO of Adobe Suzanne Nora Johnson, former Vice Chairman of Goldman Sachs James Quincey, CEO of The Coca-Cola Company James C. Smith, former CEO of Thomson Reuters Cyrus Taraporevala, former president and CEO of State Street Global Advisor
By 1980, the BSAP comprised about 46,000 personnel; 11,000 professionals (about 60% black), and the remainder reservists (mostly white). The organisation's rank structure was unique, with different levels of seniority existing for black and white officers respectively. Until 1976, black officers could rise no further than sub-inspector, while the commissioned ranks were all-white. Limitations on black aspirations were removed in 1976. The first promotion of African members to previously European-only ranks occurred on 21 October 1976 with 23 Sub-Inspectors and 8 Detective Sub-Inspectors, a week later, being promoted to Patrol Officers.
== Wife of the heir to Austrian throne == At this time, Archduke Charles was in his twenties and did not expect to become emperor for some time, especially while Franz Ferdinand remained in good health. This changed on 28 June 1914 when the heir and his wife Sophie were assassinated in Sarajevo by Bosnian Serb nationalists. Charles and Zita received the news by telegram that day. She said of her husband, "Though it was a beautiful day, I saw his face go white in the sun." In the war that followed, Charles was promoted to General in the Austro-Hungarian army, taking command of the 20th Corps for an offensive in Tyrol. The war was personally difficult for Zita, as several of her brothers fought on opposing sides in the conflict (Prince Felix and Prince René had joined the Austrian army, while Prince Sixtus and Prince Xavier lived in France before the war and enlisted in the Belgian army.) Also her country of birth, Italy, joined the war against Austria in 1915, and so rumours of the 'Italian' Zita began to be muttered. Even as late as 1917, the German ambassador in Vienna, Count Botho von Wedel-Jarlsberg, would write to Berlin saying "The Empress is descended from an Italian princely house... People do not entirely trust the Italian and her brood of relatives." At Franz Joseph's request, Zita and her children left their residence at Schloss Hetzendorf and moved into a suite of rooms at Schönbrunn Palace. Here, Zita spent many hours with the old Emperor on both formal and informal occasions, where Franz Joseph confided in her his fears for the future.
Sources: en.wikipedia.org
4 Li + 2 SOCl2 → 4 LiCl + 1⁄8 S8 + SO2 These non-rechargeable batteries have advantages over other forms of lithium batteries such as a high energy density, a wide operational temperature range, and long storage and operational lifespans. They are popular power sources for IoT devices such as asset trackers and utility meters as well as military and aircraft emergency beacons. However, their high cost, non-rechargeability, and safety concerns have limited their use in consumer devices. The contents of the batteries are very corrosive, the SO2 is toxic by inhalation, and the batteries therefore require special disposal procedures; additionally, they may explode if shorted. The technology was used on the 1997 Sojourner Mars rover.
Cocaine dependence develops after even brief periods of regular cocaine use. About 25% of adults with attention deficit hyperactivity disorder (ADHD) use cocaine, and 10% develop a cocaine use disorder during their lifetime. Because cocaine use can worsen health outcomes, adults with ADHD should be screened for cocaine use disorder and referred for treatment if needed. Cocaine-dependent patients with high neuroticism scores are more likely to experience cocaine-induced psychotic symptoms, regardless of other drug use factors, making personality assessment important for risk identification and patient warning. Cocaine withdrawal symptoms group into two types: depressive (e.g., depression, craving, insomnia) and somatic (e.g., increased appetite, fatigue). Depressive symptoms are linked to worse outcomes like longer depression, treatment, and risky behaviors.
==== Megastigmatrienone ==== Tobacco aroma is due to the presence of different volatile compounds; megastigmatrienone is the key flavor compound in tobacco. Megastigmatrienone is used as flavor in tobacco products as well. Megastigmatrienone, a cyclohexenone, and a carotenoid-derived aromatic compound, produces spice notes associated with wine. Megastigmatrienone is a metabolite of Brewer's yeast. Megastigmatrienone, as Tabanone, is manufactured by Symrise as a perfume ingredient.
== Use and effects == In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MMDA's dose as 100 to 250 mg orally and its duration as "moderate". Its onset is described as 20 to 45 minutes. The effects of MMDA have been reported to include relaxation, time dilation, empathy, passivity, compassion, changes in music perception, closed-eye visuals such as geometric patterns, open-eye visuals, dream-like states described as "brain movies", and an afterglow. It has been said to be gentler than certain other psychedelics. The drug is said to have similar effects to MDA, but to be to some extent more psychedelic in comparison.
14 November Archaeologists report the oldest likely evidence (via heated fish teeth from a deep cave) of controlled use of fire to cook food by archaic humans ~780,000 years ago. After being linked to risks for obesity, mental disorders, and potentially other health issues, a study finds a likely association between (contemporary types of) outdoor artificial light at night and diabetes. 15 November A scientific review finds that human sperm counts fell by 62% in the last 50 years and are decreasing at an accelerating rate, likely a result of factors such as poor diets, endocrine disruptors in prevalent products, unhealthy lifestyles and toxic forever chemicals in air and water. A study using neuroimaging identifies rapid GABA boosting as a major potential explanation-component for why learning is often more efficient in children. Scientists report leprosy-causing bacteria viably regenerate and rejuvenate the liver in its armadillos hosts, which may enable novel human therapies. 16 November NASA conducts the first uncrewed flight of its Space Launch System (SLS), the largest rocket in history. The onboard Orion capsule will orbit the Moon before returning to Earth, as a demonstration of planned human missions. A satellite-free GPS-alternative higher-resolution positioning system using existing telecommunications networks is demonstrated, SuperGPS.
Sources: en.wikipedia.org
Provides straightforward information about effects arising from individual compounds in complex or natural samples separated in parallel. Combines chromatographic separation with effect-directed detection using enzymatic or biological assays. Helps to select important compounds from a sample for further characterization using high-resolution mass spectrometry. Offers unique benefits such as super-hyphenation, minimum sample preparation requirements, detection of multi-modulating compounds, and distinguishing agonistic versus antagonistic effects.
In 1896, the engineer Wolfram Fuchs, based on his experience with numerous X-ray examinations, recommended keeping the exposure time as short as possible, staying away from the tube, and covering the skin with Vaseline. In 1897, Chicago doctors William Fuchs and Otto Schmidt became the first users to have to pay compensation to a patient for radiation damage. In 1901, dentist William Herbert Rollins (1852-1929) called for using lead-glass goggles when working with X-rays, for the X-ray tube to be encased in lead, and for all areas of the body to be covered with lead aprons. He published over 200 articles on the potential dangers of X-rays, but his suggestions were long ignored. A year later, Rollins wrote in despair that his warnings about the dangers of X-rays were not being heeded by either the industry or his colleagues. By this time, Rollins had demonstrated that X-rays could kill laboratory animals and induce miscarriages in guinea pigs. Rollins' achievements were not recognized until later. Since then, he has gone down in the history of radiology as the "father of radiation protection". He became a member of the Radiological Society of North America and its first treasurer.
=== Separation of cffDNA === Blood plasma is separated from the maternal blood sample using a laboratory centrifuge. The cffDNA is then isolated and purified. A standardized protocol for doing this was written through an evaluation of the scientific literature. The highest yield in cffDNA extraction was obtained with the "QIAamp DSP Virus Kit". Addition of formaldehyde to maternal blood samples increases the yield of cffDNA. Formaldehyde stabilizes intact cells, and therefore inhibits the further release of maternal DNA. With the addition of formaldehyde, the percentage of cffDNA recovered from a maternal blood sample varies between 0.32 percent and 40 percent with a mean of 7.7 percent. Without the addition of formaldehyde, the mean percentage of cffDNA recovered has been measured at 20.2 percent. However, other figures vary between 5 and 96 percent. Recovery of cffDNA may be related to the length of the DNA fragments. Another way to increase the fetal DNA is based on physical length of DNA fragments. Smaller fragments can represent up to seventy percent of the total cell free DNA in the maternal blood sample.
O.R. Tambo is focused on most of SA's manufactured exports and imports Cape Town International deals primarily with agricultural exports, such as fruit, flowers, and seafood King Shaka International supports manufacturing and automotive exports Out of all air freight flowing through South Africa's airports, O.R. Tambo handles Major players in the South African air freight sector include South African Airways Cargo, Ethiopian Cargo, Qatar Airways Cargo, Emirates SkyCargo, Lufthansa Cargo, Turkish Cargo, and Cargolux. Freight forwarders such as DHL, FedEx, UPS, and DSV also play a large role in the sector.
Sources: en.wikipedia.org
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.
Rodent studies found dose-dependent tumors in several organs. The sponsor discontinued the program over cancer concerns. Human risk from long-term use remains unknown.
Controlled human endurance trials are lacking. Animal studies show increased exercise capacity under some conditions. Anecdotal reports are not equivalent to clinical evidence.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.